My blood glucose remains in the 300–400 mg/dL range despite taking 8 units of insulin glargine (Lantus); how many additional units of insulin glargine should I increase to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Increase Lantus by 2 units every 3 days until fasting blood sugar reaches goal

With blood glucose levels in the 300-400 mg/dL range on only 8 units of Lantus, you should increase the dose by 2 units every 3 days, monitoring fasting blood glucose closely, until you reach your target fasting glucose goal (typically <100-130 mg/dL depending on individual circumstances). 111

Titration Algorithm

The 2025 ADA Standards of Care provide a clear evidence-based titration approach for basal insulin:

  • Increase by 2 units every 3 days to reach fasting plasma glucose (FPG) goal without hypoglycemia 111
  • Continue this pattern until fasting glucose normalizes
  • If hypoglycemia occurs without clear cause, reduce dose by 10-20% 1

Critical Context for Your Situation

Your current dose of 8 units is extremely low for someone with glucose levels of 300-400 mg/dL. The FDA label for Lantus recommends a starting dose of 10 units per day or 0.1-0.2 units/kg/day for type 2 diabetes 22. You're actually below the typical starting dose, which explains the inadequate control.

Expected Dose Requirements

Research demonstrates that basal insulin effectiveness follows a dose-response curve, with meaningful glycemic improvements typically requiring doses up to 0.5 units/kg/day 3. Beyond this threshold, additional increases yield diminishing returns with greater weight gain but no additional hypoglycemia risk. For most adults, this translates to doses ranging from 30-50+ units daily.

Important Considerations

Monitor for signs of overbasalization: If you reach doses approaching 0.5 units/kg/day (roughly 35-50 units for a 70-100 kg person) and fasting glucose improves but overall control remains poor, this signals the need for additional therapy rather than further basal insulin increases 11. Signs include:

  • Large gaps between bedtime and morning glucose
  • High post-meal glucose spikes
  • Continued elevated A1C despite normalized fasting glucose

At these severe glucose levels (300-400 mg/dL), consider adding prandial insulin: The guidelines specifically note that glucose ≥300 mg/dL often warrants more aggressive insulin therapy, potentially including mealtime rapid-acting insulin in addition to basal insulin 4. This may be more effective than basal insulin alone.

Alternative intensification: If not already on a GLP-1 receptor agonist (like semaglutide or tirzepatide), adding one of these medications can provide substantial glucose lowering with weight loss benefits and lower hypoglycemia risk compared to insulin intensification alone 11.

Practical Implementation

  1. Increase Lantus by 2 units every 3 days starting immediately
  2. Check fasting blood glucose daily before breakfast
  3. Target fasting glucose <130 mg/dL initially (can tighten to <100 mg/dL once stable)
  4. Continue increases until fasting glucose reaches goal
  5. Expect to need 30-50+ units based on your current glucose levels
  6. Reassess strategy if you reach 0.5 units/kg/day without adequate control

The systematic 2-unit every 3-day increase is safe, evidence-based, and will get you to an effective dose within several weeks 15.

Related Questions

What is the goal dose of Lantus (insulin glargine) for a 115‑lb (≈52‑kg) patient with an A1c of 11% who can no longer use a GLP‑1 receptor agonist?
Should I decrease my insulin glargine (Lantus) dose, currently 22 units, given a blood glucose of 219 mg/dL at 2 am and 152 mg/dL at 7 am?
In a 47-year-old male with uncontrolled diabetes (glucose 369 mg/dL) who has been off medication for over a year, can I initiate basal insulin with insulin glargine (Lantus) now?
How should the insulin regimen be adjusted for a patient with a recent A1C of 10% who is currently on sliding‑scale insulin and insulin glargine (100 U/mL)?
For a 19‑year‑old patient with type 1 diabetes weighing 86.2 kg who is currently taking insulin glargine (Lantus) 12 U at 08:00 and 35 U at 20:00 and uses insulin‑to‑carbohydrate ratios of 1 U per 5 g carbs for breakfast and lunch and 1 U per 6 g carbs for dinner, what should the basal Lantus dose and insulin‑to‑carbohydrate ratio be adjusted to?
How is an ultrasound‑guided middle cluneal nerve block performed, including medication dosage, patient positioning, and post‑procedure care?
Do hamstring tears result in long‑term work absence?
Can you help write a prior authorization for semaglutide (Ozempic) for an older male patient with hemiplegia secondary to ischemic stroke and type 2 diabetes mellitus inadequately controlled on maximally tolerated metformin?
What is the appropriate evaluation for a possible hiatal hernia?
What is the appropriate management for a patient with chronic lumbar spine pain and scoliosis?
For a 55-year-old patient with a body mass index of 32.1, blood pressure of 110/54 mmHg, total cholesterol of 226 mg/dL, LDL cholesterol of 148 mg/dL, HDL cholesterol of 55 mg/dL, triglycerides of 133 mg/dL, and VLDL cholesterol of 23 mg/dL, how should I manage their hypercholesterolemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.